G 32 250
Pill imprint G 32 250 has been identified as Naproxen 250 mg.
Naproxen is used in the treatment of pain; back pain; headache; osteoarthritis; sciatica (and more), and belongs to the drug class nonsteroidal anti-inflammatory agents. Risk cannot be ruled out during pregnancy.
Naproxen 250 mg is not subject to the Controlled Substances Act.
See also related documents.
Naproxen Images
- Imprint:
-
G 32
250 - Strength:
- 250 mg
- Color:
- Orange
- Size:
- 10.00 mm
- Shape:
- Round
- Availability:
- Rx and/or OTC
- Inactive Ingredients:
- microcrystalline cellulose
croscarmellose sodium
povidone
magnesium stearate
- Drug Class:
- Nonsteroidal anti-inflammatory agents
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- Glenmark Generics Inc.
- National Drug Code (NDC):
- 68462-0188
More Naproxen resources
- Naproxen
- Naproxen (Wolters Kluwer)
- Naproxen Enteric-Coated Tablets (Wolters Kluwer)
- Naproxen Suspension (Wolters Kluwer)
- Naproxen Sustained-Release Tablets (Wolters Kluwer)
- naproxen (Cerner Multum)
- Naprelan 500 (Micromedex) - Includes Dosage Information
- Naprelan Dose Card (Micromedex) - Includes Dosage Information
- Naxen (Micromedex) - Includes Dosage Information
- naproxen (Micromedex) - Includes Dosage Information
- Naproxen (AHFS DI)
- Naproxen Sodium (AHFS DI)
- Good Neighbor All Day Pain Relief (FDA)
- Naprosyn Tablets (FDA)
- Naproxen (FDA)
- Naproxen Capsules (FDA)
- Naproxen Delayed Release (FDA)
- Naproxen Tablets (FDA)
- Topcare All Day Pain Relief (FDA)
- Up and Up Naproxen Sodium (FDA)
- Naproxen (Wolters Kluwer)


